Aunan Greg D 4
4 · NEOGENOMICS INC · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
NeoGenomics (NEO) CAO Greg Aunan Receives Options & RSUs
What Happened Greg D. Aunan, Chief Accounting Officer of NeoGenomics, received equity awards on March 1, 2026: 36,825 stock options and 22,889 restricted stock units (RSUs). Both awards were granted at $0 acquisition price (typical for compensation grants) and are recorded as derivative/award transactions rather than open-market purchases or sales.
Key Details
- Transaction date: March 1, 2026; Form filed March 3, 2026 (timely filing).
- Grants: 36,825 stock options; 22,889 RSUs. Reported acquisition price: $0.00 (award).
- Vesting for the March 1, 2026 awards: vest ratably over the first three anniversaries of the grant date (footnotes F1–F2).
- Additional prior awards to Mr. Aunan (listed in the filing):
- 5/1/2023: 28,662 stock options (vest ratably over 4 years) (F4)
- 5/2/2024: 26,978 stock options (vest ratably over 3 years) (F5)
- 5/2/2024: 16,117 RSUs (vest ratably over 3 years) (F6)
- 2/21/2025: 31,163 stock options (vest ratably over 3 years) (F7)
- 2/21/2025: 18,971 RSUs (vest ratably over 3 years) (F8)
- Once RSUs convert to shares upon vesting, the shares are not subject to expiration (F3).
- Shares owned after the reported grants are not specified in the provided filing excerpt.
Context These entries are standard equity compensation grants to an executive (an "award" — filing code A). Grants do not involve an immediate cash outlay by the insider and are different from purchases (which can signal a personal investment). Vesting schedules mean the awards convert to actual shares over time; until vested, the options/RSUs are subject to the company’s award terms.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-03-01+36,825→ 36,825 totalExercise: $9.83Exp: 2036-03-01→ Common Stock (36,825 underlying) - Award
Restricted Stock Unit
[F2][F3]2026-03-01+22,889→ 22,889 totalExercise: $0.00→ Common Stock (22,889 underlying)
- 22,027
Common Stock
- 28,662
Stock Option (Right to Buy)
[F4]Exercise: $14.62Exp: 2030-05-01→ Common Stock (28,662 underlying) - 26,978
Stock Option (Right to Buy)
[F5]Exercise: $13.96Exp: 2034-05-02→ Common Stock (26,978 underlying) - 16,117
Restricted Stock Unit
[F6][F3]Exercise: $0.00→ Common Stock (16,117 underlying) - 31,163
Stock Option (Right to Buy)
[F7]Exercise: $11.86Exp: 2035-02-21→ Common Stock (31,163 underlying) - 12,648
Restricted Stock Unit
[F8][F3]Exercise: $0.00→ Common Stock (12,648 underlying)
Footnotes (8)
- [F1]On March 1, 2026, Mr. Aunan was granted 36,825 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On March 1, 2026, Mr. Aunan was granted 22,889 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F3]Once vested, the shares of common stock are not subject to expiration.
- [F4]On May 1, 2023, Mr. Aunan was granted 28,662 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F5]On May 2, 2024, Mr. Aunan was granted 26,978 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F6]On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F7]On February 21, 2025, Mr. Aunan was granted 31,163 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F8]On February 21, 2025, Mr. Aunan was granted 18,971 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.